{"id":743,"date":"2012-11-30T15:00:31","date_gmt":"2012-11-30T19:00:31","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/oserranob\/?p=743"},"modified":"2012-11-30T15:00:31","modified_gmt":"2012-11-30T19:00:31","slug":"diagnostico-genomico-aplicable-en-cancer","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2012\/11\/30\/diagnostico-genomico-aplicable-en-cancer\/","title":{"rendered":"Diagn\u00f3stico gen\u00f3mico aplicable en c\u00e1ncer"},"content":{"rendered":"<p>El manejo cl\u00ednico del c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y las decisiones con relaci\u00f3n a su terap\u00e9utica pueden beneficiarse de la evaluaci\u00f3n del genoma. La detecci\u00f3n de mutaciones en genes como <a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/673\" target=\"_blank\"><strong>BRAF<\/strong><\/a>, <a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/2064\" target=\"_blank\"><strong>HER2<\/strong><\/a>, <a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/5290\" target=\"_blank\"><strong>PIK3CA<\/strong><\/a>, <a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/238\" target=\"_blank\"><strong>ALK<\/strong><\/a>, <strong><a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/1956\" target=\"_blank\">EGFR<\/a> <\/strong>y <a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/3845\" target=\"_blank\"><strong>KRAS<\/strong><\/a>, en un tiempo promedio de 31 d\u00edas, ha beneficiado a m\u00e1s de 400 pacientes, seg\u00fan se informa en <a title=\"Resumen en PubMed\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23154547\" target=\"_blank\"><strong>Journal of Thoracic Oncology<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El manejo cl\u00ednico del c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y las decisiones con relaci\u00f3n a su terap\u00e9utica pueden beneficiarse de la evaluaci\u00f3n del genoma. La detecci\u00f3n de mutaciones en genes como BRAF, HER2, PIK3CA, ALK, EGFR y KRAS, en un tiempo promedio de 31 d\u00edas, ha beneficiado a m\u00e1s de 400 pacientes, seg\u00fan [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,15,21,23,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/743"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=743"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/743\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}